STEVENSON, Wash., Feb 02, 2010 (BUSINESS WIRE) -- Total Nutraceutical Solutions, Inc. (TNS) announced today that the company signed a non-exclusive agreement with Lee International Group Ltd (Lee International) to distribute TNS's human and veterinary dietary supplements in the S.E Asian markets, including Mainland China. Lee International has years of operating experience in the S.E. Asian healthcare industry, especially in Mainland China. Lee International will advise and assist TNS in the research and development of products most suitable for this market. The market includes Mainland China, Cambodia, Vietnam, Hong Kong, and Macau. The distributor will maintain an inventory of TNS products to adequately serve the demands of the market.
"This agreement opens the door for TNS to introduce its dietary supplement portfolio of products into one of the fastest growing healthcare markets in the world," stated Marvin S. Hausman MD, CEO, TNS. "The concept of an American company bringing organic mushroom-based supplements from the U.S. to S.E. Asia, especially China, a region long devoted to use of mushrooms to treat and prevent disease, is most intriguing."
About Lee International Group Ltd.:
Lee International Group Limited is based in Hong Kong and is affiliated with Lee International IP and Law Group, a leading provider of legal, commercial and business solutions headquartered in Korea. The Lee Group provides services to a wide range of clients, including some of the largest corporations in Asia. The principals of Lee Group have extensive connections and experience throughout Asia. They were also involved in the initial launching of China Healthcare Holdings, which partnered with China's Ministry of Health to provide access to private healthcare services in China. The Lee Group will work closely with Total Nutraceutical Solutions, Inc. in identifying marketing opportunities in Asia.
About Total Nutraceutical Solutions, Inc.:
Total Nutraceutical Solutions, Inc. is an emerging nutraceutical company with a focus on discovering, formulating and marketing products composed primarily of organic natural mushroom compounds that contain bioactive nutrients for potential health benefits. TNS develops production and analytic technologies for food and nutritional supplements composed primarily of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to preventative healthcare formulations and nutritional approaches to a wide variety of human conditions and illnesses, TNS also develops and acquires breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2008, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.